Observational studyAmerican journal of hematology2026

Real-World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry.

Alexander Röth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.